ArticleScientific reports2025
A fluorescence-off based approach for sensitive determination of bepotastine in pharmaceutical and biological matrices considering human safety aspects: sustainability assessment.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Green analytical evaluation of anticancer drug analysis: A multi-tool assessment of HPLC and LC-MS methods.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
A pioneering spectrofluorimetric approach was established to facilitate the precise and environmentally considerate measurement of Bepotastine (BPST), a pharmaceutical compound utilized as a novel anti-allergy treatment. The study presents a highly dependable, sensitive, and green analytical procedure for the investigation and validation of this drug. The described methodology capitalizes on the rapid electrostatic interaction that occurs between Eosin Y and Bepotastine, a non-hazardous dye approved for biological staining use, under somewhat acidic pH settings. This interaction leads to fluorescence quenching of the bio-dye, predominantly at an emission wavelength of 556 nm. Outstanding analytical considerations were achieved, including detecting and measuring thresholds of 30.8 ng/mL and 93.5 ng/mL, respectively, across the linear working range of 100-1900 ng/mL. Extensive optimization studies were conducted to refine the conditions impacting the complexation mechanism between molecules of both the drug and the bio-dye. Rigorous validation demonstrated full compliance with ICH standards, confirming the method's accuracy and precision. The developed method demonstrated high analytical accuracy, with recovery values ranging from 98.63% to 100.15% (relative error: -0.15-1.37%), and excellent precision, reflected by SD and RSD values < 2.0%. The method also exhibited remarkable ruggedness and robustness (RSD ≤ 1.64%), confirming its reliability and suitability for advanced analytical applications. This novel procedure was effectively employed for the evaluation of BPST in its raw state, pharmaceutical formulations, and various matrices. From an ecological viewpoint, the procedure was thoroughly assessed for sustainability using advanced green chemistry tools. Comprehensive evaluation using eight internationally recognized green assessment tools (Analytical Eco-Scale, AGREE, MoGAPI, ComplexMoGAPI, CaFRI, CACI, BAGI, and AGSA) confirmed the superior greenness and analytical reliability of the proposed method, establishing it as a sustainable and efficient choice for routine determination of bepotastine in pharmaceutical and biological samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.